1. Home
  2. MVSTW vs MIST Comparison

MVSTW vs MIST Comparison

Compare MVSTW & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microvast Holdings Inc.

MVSTW

Microvast Holdings Inc.

HOLD

Current Price

$0.00

Market Cap

0.0

Sector

Miscellaneous

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.32

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVSTW
MIST
Founded
2006
2003
Country
United States
Canada
Employees
1908
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
176.3M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MVSTW
MIST
Price
$0.00
$1.32
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
100.5K
1.4M
Earning Date
03-14-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$370,989,000.00
N/A
Revenue This Year
N/A
$2,915.14
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.03
N/A
52 Week Low
$0.00
$1.00
52 Week High
$0.65
$3.06

Technical Indicators

Market Signals
Indicator
MVSTW
MIST
Relative Strength Index (RSI) 27.32 45.54
Support Level N/A $1.20
Resistance Level $0.02 $1.42
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.02
Stochastic Oscillator 3.75 54.55

Price Performance

Historical Comparison
MVSTW
MIST

About MVSTW Microvast Holdings Inc.

Microvast Holdings Inc develops lithium-ion battery technologies focused on high-performance solutions for commercial and industrial electrification. The Company designs, develops, and manufactures battery components and systems for electric commercial vehicles and energy storage systems (ESS), with applications across buses, trucks, port equipment, and mining machinery. It emphasizes innovation in battery design without relying on legacy technologies and supports platforms such as the IVECO eDaily and various bus models. The Company also provides services, repairs, and warranty and extended warranty support. It operates as a single reportable segment, covering design, development, manufacturing, sales, and leasing of battery systems, and generates the majority of its revenue from Europe.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: